|
1
|
Griffiths CEM, Armstrong AW, Gudjonsson JE
and Barker JNWN: Psoriasis. Lancet. 397:1301–131. 2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Moon CI, Lee J, Baek YS and Lee O:
Psoriasis severity classification based on adaptive multi-scale
features for multi-severity disease. Sci Rep.
13(17331)2023.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Pudgerd A, Jongsomchai K, Muangkaew W,
Phuapittayalert L, Jamsuwan S, Chanmanee T, Vanichviriyakit R and
Sukphopetch P: A tryptophol-containing emulgel ameliorates
imiquimod-induced mice psoriasis. Sci Rep. 15(19398)2025.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Elmets CA, Leonardi CL, Davis DMR, Gelfand
JM, Lichten J, Mehta NN, Armstrong AW, Connor C, Cordoro KM,
Elewski BE, et al: Joint AAD-NPF guidelines of care for the
management and treatment of psoriasis with awareness and attention
to comorbidities. J Am Acad Dermatol. 80:1073–1113. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Liu M, Fan R, Chen L, Zhang D and Chen C:
Hydroxytyrosol ameliorates imiquimod-induced psoriasis-like
dermatitis by modulating ERK and NF-κB signaling pathways in mice.
Sci Rep. 15(30125)2025.PubMed/NCBI View Article : Google Scholar
|
|
6
|
van der Fits L, Mourits S, Voerman JSA,
Kant M, Boon L, Laman JD, Cornelissen F, Mus AM, Florencia E, Prens
EP and Lubberts E: Imiquimod-induced psoriasis-like skin
inflammation in mice is mediated via the IL-23/IL-17 axis. J
Immunol. 182:5836–5845. 2009.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Bugaut H and Aractingi S: Major role of
the IL17/23 axis in psoriasis supports the development of new
targeted therapies. Front Immunol. 12(621956)2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yao Y, Chen LQ, Lv B, Tang S, Shen W, Sun
H and Zhong HJ: Skin immune microenvironment in psoriasis: From
bench to bedside. Front Immunol. 16(1643418)2025.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Xie X, Zhang L, Lin Y, Liu X, Wang N and
Li P: IL-17A exacerbates psoriasis in a STAT3 overexpressing mouse
model. PeerJ. 11(e15727)2023.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ma C, Gu C, Lian P, Wazir J, Lu R, Ruan B,
Wei L, Li L, Pu W, Peng Z, et al: Sulforaphane alleviates psoriasis
by enhancing antioxidant defense through KEAP1-NRF2 pathway
activation and attenuating inflammatory signaling. Cell Death Dis.
14(768)2023.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ahmed SM, Luo L, Namani A, Wang XJ and
Tang X: Nrf2 signaling pathway: Pivotal roles in inflammation.
Biochim Biophys Acta Mol Basis Dis. 1863:585–597. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Salman S, Paulet V, Hardonnière K and
Kerdine-Römer S: The role of NRF2 transcription factor in
inflammatory skin diseases. Biofactors. 51(e70013)2025.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Furue M: Regulation of filaggrin,
loricrin, and involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and
NRF2: Pathogenic implications in atopic dermatitis. Int J Mol Sci.
21(5382)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Jeon S, Kim NH, Koo BS, Kim JY and Lee AY:
Lotus (Nelumbo nuficera) flower essential oil increased
melanogenesis in normal human melanocytes. Exp Mol Med. 41:517–525.
2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kongsui R, Chanmanee T, Promsrisuk T,
Klimaschewski L, Sriraksa N, Jittiwat J and Thongrong S:
Neuroprotective effects of pink lotus oil in kainic acid-induced
epilepsy. Heliyon. 10(e38070)2024.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Sriraksa N, Kongsui R and Thongrong S:
Lotus essential oil improves neurite elongation and facilitates
functional recovery after peripheral nerve injury. Biomed Rep.
16(30)2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lv L, Jiang C, Li J and Zheng T:
Protective effects of lotus (Nelumbo nucifera Gaertn) germ
oil against carbon tetrachloride-induced injury in mice and
cultured PC-12 cells. Food Chem Toxicol. 50:1447–1453.
2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Tseng HC, Tsai PM, Chou YH, Lee YC, Lin HH
and Chen JH: In vitro and in vivo protective effects of
flavonoid-enriched lotus seedpod extract on
lipopolysaccharide-induced hepatic inflammation. Am J Chin Med.
47:153–176. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sun R, Xiao R, Lv P, Guo F, Gong Y and Yan
M: Pink lotus essential oil and alleviates on free fatty acid
induced steatosis in HepG2 cells via PI3K/Akt and NF-κB pathways. J
Oleo Sci. 71:95–104. 2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zong J, Cheng J, Fu Y, Song J, Pan W, Yang
L, Zhang T and Zhou M: Serum metabolomic profiling reveals the
amelioration effect of methotrexate on imiquimod-induced psoriasis
in mouse. Front Pharmacol. 11(558629)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Promsrisuk T, Kongsui R, Sriraksa N,
Boonla O and Srithawong A: Elastic band resistance combined with
modified Thai yoga exercise to alleviate oxidative stress and
airway inflammation in type 2 diabetes mellitus. J Exerc Rehabil.
19:114–125. 2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Liu X, Du S, Jiang Y and Chen Y: Piezo1
exacerbates psoriasis by promoting macrophage M1 polarization and
inhibits autophagy via activating PI3K/AKT signaling pathway.
Inflamm Res. 74(149)2025.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wawersik MJ, Mazzalupo S, Nguyen D and
Coulombe PA: Increased levels of keratin 16 alter epithelialization
potential of mouse skin keratinocytes in vivo and ex vivo. Mol Biol
Cell. 12:3439–3450. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhang X, Yin M and Zhang LJ: Keratin 6, 16
and 17-critical barrier alarmin molecules in skin wounds and
psoriasis. Cells. 8(807)2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Xiao CY, Zhu ZL, Zhang C, Fu M, Qiao HJ,
Wang G and Dang EL: Small interfering RNA targeting of keratin 17
reduces inflammation in imiquimod-induced psoriasis-like
dermatitis. Chin Med J (Engl). 133:2910–2918. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Jongsomchai K, Pudgerd A, Phuapittayalert
L, Jamsuwan S, Chanmanee T, Wongprasert K, Promthale P and
Rudtanatip T: Low molecular weight sulfated galactan attenuates
imiquimod-induced psoriasis via suppression of proinflammatory
cytokines and keratinocyte hyperproliferation. Biomed Rep.
23(190)2025.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Nakahara T, Mitoma C, Hashimoto-Hachiya A,
Takahara M, Tsuji G, Uchi H, Yan X, Hachisuka J, Chiba T, Esaki H,
et al: Antioxidant opuntia ficus-indica extract activates AHR-NRF2
signaling and upregulates filaggrin and loricrin expression in
human keratinocytes. J Med Food. 18:1143–1149. 2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Hatem S and El-Kayal M: Novel
anti-psoriatic nanostructured lipid carriers for the cutaneous
delivery of luteolin: A comprehensive in-vitro and in-vivo
evaluation. Eur J Pharm Sci. 191(106612)2023.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Mustafa AM, Atwa AM, Elgindy AM, Alkabbani
MA, Ibrahim KM, Esmail MM, El Shiekh RA, Mohamed EM and Kamel KM:
Targeting psoriatic inflammation with natural compounds:
Mechanistic insights and therapeutic promise. Inflammopharmacology.
33:3843–3870. 2025.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wang X, Jia Y and He H: The role of
linoleic acid in skin and hair health: A review. Int J Mol Med.
26(246)2024.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ziboh VA, Miller CC and Cho Y: Metabolism
of polyunsaturated fatty acids by skin epidermal enzymes:
Generation of antiinflammatory and antiproliferative metabolites.
Am J Clin Nutr. 71 (Suppl 1):361S–366S. 2000.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Lowes MA, Suárez-Fariñas M and Krueger JG:
Immunology of psoriasis. Annu Rev Immunol. 32:227–255.
2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Rendon A and Schäkel K: Psoriasis
pathogenesis and treatment. Int J Mol Sci. 20(1475)2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Calautti E, Avalle L and Poli V:
Psoriasis: A STAT3-centric view. Int J Mol Sci.
19(171)2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wu P, Liu Y, Zhai H, Wu X and Liu A: Rutin
alleviates psoriasis-related inflammation in keratinocytes by
regulating the JAK2/STAT3 signaling. Skin Res Technol.
30(e70011)2024.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Lee JY, Lee HJ, Jeong JA and Jung JW:
Palmitic acid inhibits inflammatory responses in
lipopolysaccharide-stimulated mouse peritoneal macrophages. Adv
Tradit Med. 10:37–43. 2010.
|
|
38
|
Korbecki J and Bajdak-Rusinek K: The
effect of palmitic acid on inflammatory response in macrophages: An
overview of molecular mechanisms. Inflamm Res. 68:915–932.
2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Nimgampalle M, Bhat AR, Perumal M, Ganesh
PSKP, Purushothaman G and Devanathan V: Alleviated
neuroinflammation and increased neuritogenesis by palmitic acid
from Cissus quadrangularis. Mol Neurobiol. 62:10165–10181.
2025.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Hu Y, Liang X, Li X, Han Y and Lang G:
Rutin ameliorates imiquimod-induced psoriasis-like skin lesions by
inhibiting oxidative stress injury and the inflammatory response in
mice via the Keap1/Nrf2 signaling pathway. Sci Rep.
15(20712)2025.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Zhang P, Su Y, Li S, Chen H, Wu R and Wu
H: The roles of T cells in psoriasis. Front Immunol.
14(1081256)2023.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Li L, Lu J, Liu J, Wu J, Zhang X, Meng Y,
Wu X, Tai Z, Zhu Q and Chen Z: Immune cells in the epithelial
immune microenvironment of psoriasis: Emerging therapeutic targets.
Front Immunol. 14(1340677)2024.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Revu S, Wu J, Henkel M, Rittenhouse N,
Menk A, Delgoffe GM, Poholek AC and McGeachy MJ: IL-23 and IL-1β
drive human Th17 cell differentiation and metabolic reprogramming
in absence of CD28 costimulation. Cell Rep. 22:2642–2653.
2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Di Cesare A, Di Meglio P and Nestle FO:
The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J
Invest Dermatol. 129:1339–1350. 2009.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Tessmer MS, Fatima A, Paget C, Trottein F
and Brossay L: NKT cell immune responses to viral infection. Expert
Opin Ther Targets. 13:153–162. 2009.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Cai Y, Xue F, Quan C, Qu M, Liu N, Zhang
Y, Fleming C, Hu X, Zhang H, Weichselbaum R, et al: A critical role
of the IL-1β-IL-1R signaling pathway in skin inflammation and
psoriasis pathogenesis. J Invest Dermatol. 139:146–156.
2019.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Christmann C, Zenker S, Martens L, Hübner
J, Loser K, Vogl T and Roth J: Interleukin 17 promotes expression
of alarmins S100A8 and S100A9 during the inflammatory response of
keratinocytes. Front Immunol. 11(599947)2021.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Yang D, Elner SG, Bian ZM, Till GO, Petty
HR and Elner VM: Pro-inflammatory cytokines increase reactive
oxygen species through mitochondria and NADPH oxidase in cultured
RPE cells. Exp Eye Res. 85:462–472. 2007.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Zhang X, Cao J, Zhao S, Yang X, Dong J,
Tan Y, Yu T and He Y: Nociceptive sensory fibers drive
interleukin-23 production in a murine model of psoriasis via
calcitonin gene-related peptide. Front Immunol.
12(743675)2021.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Furtunescu AR, Georgescu SR, Tampa M and
Matei C: Inhibition of the JAK-STAT pathway in the treatment of
psoriasis: A review of the literature. Int J Mol Sci.
25(4681)2024.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Ren J, Chen X, Wang HY, Yang T, Zhang KR,
Lei SY, Qi LY, Feng CL, Zhou R, Zhou H and Tan W: Gentiopicroside
ameliorates psoriasis-like skin lesions in mice via regulating the
Keap1-Nrf2 pathway and inhibiting keratinocyte activation. Acta
Pharmacol Sin. 46:1361–1374. 2025.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Yan H and Wang G: Modulation of the
KEAP1-NRF2 pathway by Erianin: A novel approach to reduce
psoriasiform inflammation and inflammatory signaling. Open Life
Sci. 20(20251139)2025.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Kim BE, Howell MD, Guttman E, Gilleaudeau
PM, Cardinale IR, Boguniewicz M, Krueger JG and Leung DYM: TNF-α
downregulates filaggrin and loricrin through c-Jun N-terminal
kinase: Role for TNF-α antagonists to improve skin barrier. J
Invest Dermatol. 131:1272–1279. 2011.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Bhol NK, Bhanjadeo MM, Singh AK, Dash UC,
Ojha RR, Majhi S, Duttaroy AK and Jena AB: The interplay between
cytokines, inflammation, and antioxidants: Mechanistic insights and
therapeutic potentials of various antioxidants and anti-cytokine
compounds. Biomed Pharmacother. 178(117177)2024.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Kim SK, Kim SB, Lee SB, Kim KS, Son SR,
Choi EJ, Park BC, Hong E, Kim YA, Moon BS and Lee S: Investigating
the antioxidant and anti-inflammatory potential of Nypa fruticans:
A multifaceted approach to skin protection and aging. Appl Biol
Chem. 68(6)2025.
|
|
56
|
Lee YJ, Bae JH, Kang SG, Cho SW, Chun DI,
Nam SM, Kim CH, Nam HS, Lee SH, Lee SH and Cho MK: Pro-oxidant
status and Nrf2 levels in psoriasis vulgaris skin tissues and
dimethyl fumarate-treated HaCaT cells. Arch Pharm Res.
40:1105–1116. 2017.PubMed/NCBI View Article : Google Scholar
|
